Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins
暂无分享,去创建一个
[1] Mingyao Liu,et al. Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. , 2008, Cancer research.
[2] Yong Yang,et al. Inhibition of glioblastoma growth and angiogenesis by gambogic acid: an in vitro and in vivo study. , 2008, Biochemical pharmacology.
[3] B. Aggarwal,et al. Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway. , 2007, Blood.
[4] Yong Yang,et al. Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes. , 2007, Cancer letters.
[5] Jian Ding,et al. Gambogic acid inhibits the catalytic activity of human topoisomerase IIα by binding to its ATPase domain , 2007, Molecular Cancer Therapeutics.
[6] Hai-wei Zhang,et al. Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells. , 2006, Carcinogenesis.
[7] J C Reed,et al. Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins , 2006, Cell Death and Differentiation.
[8] Q. Qi,et al. Toxicological studies of gambogic acid and its potential targets in experimental animals. , 2006, Basic & clinical pharmacology & toxicology.
[9] D. Green,et al. A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[10] John Calvin Reed,et al. Apoptosis-based therapies for hematologic malignancies. , 2005, Blood.
[11] John Calvin Reed,et al. Humanin Binds and Nullifies Bid Activity by Blocking Its Activation of Bax and Bak* , 2005, Journal of Biological Chemistry.
[12] John Calvin Reed,et al. Cytoprotective Peptide Humanin Binds and Inhibits Proapoptotic Bcl-2/Bax Family Protein BimEL* , 2005, Journal of Biological Chemistry.
[13] T. Kuwana,et al. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. , 2005, Molecular cell.
[14] Brian J. Smith,et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. , 2005, Molecular cell.
[15] G. Prendergast. Molecular cancer therapeutics : strategies for drug discovery and development , 2005 .
[16] J. Becker,et al. Immunogenicity of Bcl-2 in patients with cancer. , 2005, Blood.
[17] S. Korsmeyer,et al. Antiapoptotic BCL-2 is required for maintenance of a model leukemia. , 2004, Cancer cell.
[18] Maurizio Pellecchia,et al. Targeting apoptosis via chemical design: inhibition of bid-induced cell death by small organic molecules. , 2004, Chemistry & biology.
[19] Q. You,et al. Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. , 2004, Biological & pharmaceutical bulletin.
[20] A. Godzik,et al. The Domains of Apoptosis: A Genomics Perspective , 2004, Science's STKE.
[21] Xiaodong Wang,et al. Mitochondrial activation of apoptosis , 2004, Cell.
[22] S. Kasibhatla,et al. Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay. , 2004, Bioorganic & medicinal chemistry.
[23] John Calvin Reed,et al. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. , 2003, Cancer research.
[24] A. Godzik,et al. Characterization of the anti-apoptotic mechanism of Bcl-B. , 2003, The Biochemical journal.
[25] John Calvin Reed,et al. Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins. , 2003, Journal of medicinal chemistry.
[26] M. Minden,et al. Bcl-2 and apoptosis in chronic lymphocytic leukemia , 2003, Current treatment options in oncology.
[27] S. Cory,et al. The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.
[28] S. Korsmeyer,et al. Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.
[29] Robert L Moritz,et al. Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins , 2000, Cell.
[30] Xiaodong Wang,et al. Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition , 2000, Cell.
[31] M. Konopleva,et al. Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins. , 2000, Blood.
[32] Guido Kroemer,et al. Mitochondrial control of cell death , 2000, Nature Medicine.
[33] S. Cory,et al. The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.
[34] John Calvin Reed. Double identity for proteins of the Bcl-2 family , 1997, Nature.
[35] John Calvin Reed,et al. Expression of bcl-2 and the progression of human and rodent prostatic cancers. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] H. Perlman,et al. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. , 1995, Cancer research.
[37] John Calvin Reed. Apoptosis-targeted therapies for cancer. , 2003, Cancer cell.
[38] E. Smeland,et al. Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. , 1996, Cancer research.